The skeletal muscle of obese humans is characterized by an inability to appropriately respond to alterations in substrate availability. The purpose of this study was to determine if this metabolic inflexibility with obesity is retained in mitochondria of human skeletal muscle cells raised in culture (HSkMC) and to identify potential mechanisms involved. DESIGN: Mitochondrial respiration was measured in permeabilized myotubes cultured from lean and obese individuals before and after a 24-h lipid incubation. RESULTS: Mitochondrial respiration (state 3) in the presence of lipid substrate (palmitoyl carnitine) increased by almost twofold after lipid incubation in HSkMC from lean, but not obese subjects, indicative of metabolic inflexibility with obesity. The 24-h lipid incubation increased mitochondrial DNA (mtDNA) copy number in HSkMC from lean subjects by þ 16% (Po0.05); conversely, mtDNA copy number decreased in myotubes cultured from obese individuals (À13%, P ¼ 0.06). When respiration data were normalized to mtDNA copy number and other indices of mitochondrial content (COX-IV protein content and CS activity), the significant treatment effects of lipid incubation persisted in the lean subjects, suggesting concomitant alterations in mitochondrial function; no similar adjustment was evident in HSkMC from obese individuals. CONCLUSION: These data indicate that the skeletal muscle of obese individuals inherently lacks metabolic flexibility in response to lipid exposure, which consists of an inability to increase mitochondrial respiration in the presence of lipid substrate and perhaps by an inability to induce mitochondrial proliferation.
INTRODUCTION
Lipid oxidation in skeletal muscle is reported to be reduced in obese and insulin-resistant populations. 1 --4 Similarly, the skeletal muscle of obese humans typically displays a phenotype characterized by intracellular lipid accumulation 5 and reduced overall oxidative capacity. 3,6 --8 Some suggest that this reduced oxidative capacity is primarily attributable to a reduction in mitochondrial content with obesity and/or type 2 diabetes; 9 --11 however, there are also findings indicating that the existing mitochondria are unable to effectively oxidize substrates. 8, 12 Emerging evidence suggests that an inability to adapt to a metabolic challenge, such as insulin stimulation or lipid exposure (metabolic flexibility) may be an important aspect of the oxidative impairment in the obese/ diabetic phenotype 3, 13, 14 (for review, see Kelley and Mandarino 15 ). More importantly, chronic lipid exposure may exacerbate these phenotypic differences. 13, 16 We have observed that lipid oxidation is reduced in skeletal muscle and primary human skeletal muscle cell cultures (HSkMC) from obese individuals 1, 2, 4, 17 and others have reported reduced lipid oxidation in HSkMC derived from obese, type 2 diabetics. 18, 19 Corpeleijn et al. 20 recently demonstrated that 2 days of lipid incubation induced a large increase in 14 CO 2 production from 14 C-labeled oleate in myotubes cultured from lean, insulin-sensitive humans, whereas increases in cells cultured from obese, type 2 diabetic humans were 50% lower. Others have shown that a similar lipid-induced increase in HSkMC 14 CO 2 production is correlated with in vivo metabolism. 14 These findings suggest that metabolic inflexibility is preserved in HSkMC, although the effect of obesity alone and the role of mitochondrial function is not yet evident. Providing such data by measuring respiration in intact mitochondria could reveal whether mitochondrial function per se has a role in the phenotypic differences in oxidative metabolism observed in the skeletal muscle of obese, insulin-resistant populations.
In this study, by permeabilizing the cell membrane of primary human myotubes undergoing lipid pre-incubation (24 h), we measured mitochondrial respiration in skeletal muscle cells from obese and lean humans in the presence of a lipid substrate under various physiological and supra-physiological conditions (basal, adenosine diphosphate (ADP) stimulated, and chemically uncoupled), while leaving the mitochondrial structure and membrane intact. Data were also normalized to indices of mitochondrial content to determine if differences were due to mitochondrial function as opposed to overall content. We hypothesized that HSkMC harvested from obese, insulin-resistant subjects would display an inability to appropriately regulate mitochondrial respiration in response to lipid pre-incubation. ) Caucasian males (ages 18 --27 years). Participants were free from disease, nonsmokers and not taking medications known to alter metabolism. All participants had maintained a constant body mass ( ± 2 kg) in the 6 months before the biopsy. The protocol was approved by the East Carolina University Policy and Review Committee on Human Research, and informed consent was obtained. Subject characteristics are presented in Table 1 .
MATERIALS AND METHODS

Primary HSkMC
Satellite cells were isolated from 50 to 100 mg of fresh muscle tissue and cultured as previously described to ensure purity. 1, 17, 21 For experiments, cells were thawed and sub-cultured to confluence into T-75 flasks. At 80 --90% confluence, differentiation was induced by changing to lowserum differentiation media containing 2% heat-inactivated horse-serum. Starting on day 6 of differentiation, cells were incubated for 24 h in differentiation media supplemented with either 0.1% bovine serum albumin (BSA) (CONTROL) or 100 mM oleate:palmitate (1:1 ratio) bound to 0.1% BSA plus 2 mM carnitine (LIPID), after which the cells were permeabilized with digitonin and the respirometry experiments were performed. Separate aliquots of the same passage number were grown and treated similarly, then harvested for the analysis of protein content and mtDNA copy number.
Respirometry experiments
Myotubes were lifted from culture flasks with 0.05% trypsin EDTA, centrifuged for 10 min at 1000 r.p.m. at room temperature, and resuspended in warmed Dulbecco's modified Eagle's medium. An aliquot of these cells was used for normalization. Harvested myotubes were centrifuged for an additional 5 min at 500 r.p.m., the supernatant discarded, and cells resuspended in room temperature respiration buffer (130 mM sucrose, 60 mM potassium gluconate, 3 mM magnesium chloride, 10 mM potassium phosphate, 20 mM HEPES, 0.1% BSA; pH 7.4) supplemented with fresh EGTA (1 mM, pH 7.4) and digitonin (7 --10 mg per 10 6 cells) and immediately transferred to a respiration chamber (B1 --1.5 Â 10 6 cells per 2 ml) (Oroboros Oxygraph-2K, Oroboros Instruments Corp., Innsbruck, Austria). Once oxygen concentration flux stabilized, substrates were added as described in Table 2 allowing for flux stabilization between each addition. Side-by-side experiments for CONTROL and LIPID were performed on cells from each subject. The most stable portion of the oxygen concentration slope was determined for each condition and normalized to cell count as in previous cell culture respiration studies, 22 --24 and to separate indices of mitochondrial content as previously reported in permeabilized muscle fiber experiments. 6, 9, 12 Both methods were chosen to best reference our data to existing reports in terms of 'per cell' and 'per mitochondrion' respiration rates.
Specific substrate additions allowed for measurement of state 4 (substrate only, no ADP added), state 3 ( þ 2 mM ADP), state 2 ( þ oligomycin) and chemically uncoupled ( þ carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP)) respiration rates. Respiration supported exclusively by lipid (palmitoyl carnitine, PC) under state 4 (PCM 4 ), state 3 (PCM 3 ), or under the convergence of both lipid and carbohydrate substrates through mitochondrial complexes I and II (PCMGS 3 ) were also measured (see Table 2 ).
Substrate concentrations were chosen to produce a maximal substratespecific stimulus. In preliminary experiments, we determined that 5 mM PC was sufficient to induce maximal responses in respiration; and titrations up to 100 mM did not induce additional oxygen consumption. Substrates were prepared at pH 7.4 and frozen (À20 1C) in single use aliquots. Preliminary experiments were also conducted to assure permeabilized cell integrity. Addition of cytochrome C (10 mM, Table 2, step 4) was performed to determine intactness of the outer mitochondrial membrane and no change in respiration was noted following cytochrome C addition for either group (all data ± 5% from previous measure). To assess possible cell death as a result of trypsinization, we measured whole cell viability using Trypan blue (all samples were 95 --100% viable) and data were normalized to these numbers. To determine the possible ramifications of permeabilizing differentiated myotubes in a suspension, we also repeated similar permeabilization experiments on adhered cells using the same digitonin and respiration buffer parameters with the Seahorse Flux Analyzer XF-24 (Seahorse Bioscience, Billerica, MA, USA). Comparable representative tracings from suspended (n ¼ 16 repeats) and adhered (n ¼ 6 repeats) permeabilized cell preparations are shown in Figure 1 . Assessments were comparable between the two methodologies and trypsinization did not adversely affect cell permeabilization or integrity. Therefore, we chose to use the Oroboros for subsequent experiments because of the ability to assess a greater number of parameters and substrate titrations in succession. In addition, the greater cost of the Seahorse Flux Analyzer may limit the use of these methods while the Oroboros, or other Clark electrodes, are typically more accessible. Proteins were visualized by horseradish peroxidase-conjugated immunoglobulin G. COX-IV and PGC-1a antibodies were purchased from Cell Signaling (Danvers, MA, USA). Nuclear respiratory factor-1 antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Mitochondrial content
Myotubes were harvested from CONTROL and LIPID using a 10% sodium dodecyl sulfate solution (pH 8.0) containing proteinase K (Qiagen Inc.;
Valencia, CA, USA) and rocked overnight at 50 1C. DNA was isolated by phenol/chloroform extraction with ethanol precipitation and re-suspended in 10 mM Tris, 0.1 mM EDTA. Mitochondrial DNA (mtDNA) copy number was then measured as previously described. 17 For measurement of citrate synthase (CS) activity cells were harvested from control and lipid treated flasks using a 100 mM potassium phosphate solution containing 0.05% BSA. Cells were briefly sonicated and 20 ml of each sample was incubated at 25 1C in 200 ml of a freshly prepared assay solution (72.5 mM Tris, 110 mM 5,5-dithiobis(2-nitrobenzoic acid), and 79.5 mM acetyl CoA; pH 8.3). The reaction was initiated with the addition of 1.75 mM oxaloacetate, and read at 412 nm every 50 s for 10 cycles. The slope of each sample normalized for a blank control, measurement duration, sample dilution, molar extinction coefficient of 5,5-dithiobis (2-nitrobenzoic acid) and protein content.
For data normalization to mitochondrial content, three separate indices were used and normalized to baseline oxygen flux (pre-PCM addition). MtDNA copy number was referenced to cell number (mtDNA copy number per cell count). Respiration data were then normalized to this number (PCM 3 divided by (mtDNA copy number per cell count)). Respiration data were normalized similarly for COX-IV protein content and CS activity.
Statistical analyses
Statistical analyses were performed using PASW Statistics 18 Software (SPSS Inc., Chicago, IL, USA) on raw or log-transformed data. For participant characteristics, independent t-tests were performed. Two-way analysis of variance with repeated measures was used to compare differences between control and lipid-incubated cells cultured from lean and obese subjects. All data met assumptions of sphericity and homogeneity of variance. Data are presented as the mean±s.e.m.
RESULTS
Participant characteristics
Participant characteristics are presented in Table 1 . By design, the obese subjects were heavier and most had a body mass index indicative of class II or III obesity (35 --39.9 or 440 kg m --2 , respectively). Fasting blood glucose and triglyceride values did not differ between the groups, although insulin levels and homeostatic model assessment values were higher in the obese subjects.
Respirometry
For all measurements, respiration chamber oxygen concentrations were well above values required for normal respiration (B130 to B180 mm Hg). In Figure 2 , mean oxygen flux data are presented for each group following normalization to cell count. Baseline oxygen flux was not different from PCM 4 condition (Figure 2) . Under CONTROL respiration rates, PCM 3 did not differ in HSkMC from lean and obese subjects (see Table 2 for notation details). However, state 3 respiration supported by lipid only (PCM 3 ) increased by approximately twofold in HSkMC from lean subjects in response to the 24-h lipid incubation (LIPID). There was a much less robust response in cells from obese subjects ( þ 13%; Figure 2 . Mean state 4 and state 3 respiration rates in permeabilized myotubes cultured from lean (n ¼ 7) and obese (n ¼ 7) subjects in the presence of PCM, ADP, CytC and G (see Table 2 for abbreviation details). Cells were pre-incubated for 24 h in either CONTROL or LIPID treatments. Data are presented as the mean of the oxygen flux per second normalized to total cell count. There was a significant body type Â lipid treatment interaction for PCM 3 (Po0.05). interaction Po0.05; Figure 2 Indices of mitochondrial content As presented in Figure 3a , myotubes cultured from lean and obese individuals responded differently to the 24-h lipid treatment in terms of mtDNA copy number (Po0.05), such that copy number increased in cells cultured from lean subjects and decreased in cells cultured from obese subjects ( þ 16% and À13% in lean and obese, respectively). There was a similar trend for COX-IV protein content (P ¼ 0.09) (Figure 3b ). CS activity (Figure 3c) was not altered.
PGC-1a protein content was measured in an attempt to discern mechanisms linked with the possible alterations in mitochondrial content with lipid exposure (Figure 3 ). PGC-1a protein content was not different between cells from lean and obese individuals and was unchanged with lipid incubation (À1% and þ 3% in cells from lean and obese, respectively; not significant). Changes in nuclear respiratory factor-1 protein content with lipid incubation were also not significant ( þ 25% and þ 18% in cells from lean and obese, respectively; not significant) and did not differ between the groups.
Respiration normalized to mitochondrial content To account for possible differences in respiration relative to mitochondrial content, state 3 respiration rates (PCM 3 ) were normalized to the three indices of mitochondrial content as presented in Figure 4 . A significant LIPID treatment effect was noted for data normalized to mtDNA (Po0.05), which appeared to be mainly driven by the increase in PCM 3 /mtDNA in cells cultured from the lean donors (Figure 4a) , as suggested by a trend for a significant interaction effect (P ¼ 0.08). No interaction or LIPID treatment effects were noted when data were normalized to COX-IV protein content (Figure 4b , P ¼ 0.7). When data were normalized to CS activity there was a significant LIPID treatment effect (Po0.05) and a trend for a significant interaction (P ¼ 0.07), again suggesting that the increases in respiration with LIPID were mainly driven by changes in the cells cultured from lean humans (Figure 4c ). Together, these data suggest that HSkMC from lean humans exhibit some degree of metabolic flexibility in response to 24 h of mixed-lipid exposure in terms of increasing respiration on 'per mitochondria' basis. This flexibility is dampened or not evident in the cells from the obese humans.
Flux control ratios The coupled control ration was calculated (uncoupled respiration divided by state 3 respiration through complexes I and II (PCMGS 3 )) to determine any potential limitation in the phosphorylation system relative to the overall capacity of the electron transport system. 25 coupled control ration was not different in cells from lean and obese subjects and did not change as a result of LIPID (Figure 5a ). All coupled control ration values were 41.0, indicating that the electron transport capacity was not limiting oxygen consumption in either control or lipid-incubated cells in either group. A substrate control ratio was also calculated for PCM (state 3 respiration (PCM 3 ) divided by state 4 respiration (PCM 4 )) as an index of the metabolic coupling of mitochondrial respiration and oxidative phosphorylation. 25 There was a significant interaction between cells cultured from lean and obese subjects (Po0.05, Figure 5b ) where cells from lean subjects increased in response to lipid incubation. These treatment effects are accounted for by increased PCM 3 rather than decreased PCM 4 , which indicates that mitochondrial coupling was not negatively affected by LIPID.
DISCUSSION
The main finding of this study was that skeletal muscle cells derived from obese humans failed to upregulate mitochondrial respiration in response to a 24-h lipid incubation (LIPID), while myotubes cultured from lean humans increased state 3 respiration using lipid as a substrate (Figure 2 ). This impairment in the ability to increase lipid oxidation to a similar extent to that observed in the HSkMC from the lean subjects persisted in the obese subjects when respiration was normalized to mtDNA and CS activity (Figure 4) . Cells from the lean subjects exhibited increased mtDNA copy number following LIPID treatment, although a similar response was not evident in HSkMC from obese subjects. A similar trend was noted for COX-IV protein content (P ¼ 0.09) (Figure 3) . The current data, therefore, indicate that there is a metabolic inflexibility in the skeletal muscle of obese individuals in terms of increasing mitochondrial lipid oxidation in response to lipid exposure. A novel aspect of these findings is that this inflexibility appears to result from an impaired ability to intrinsically enhance the capacity for lipid oxidation in response to increased lipid availability and may also result from an impaired ability to increase mitochondrial content.
With HSkMC the processes of cellular proliferation and differentiation take place outside of the in-vivo environment; expression of a given characteristic in HSkMC has thus been interpreted as indicating that innate genetic and/or epigenetic traits are involved. 19, 26, 27 In-vivo studies indicate that lean individuals can respond to an increase in dietary fat intake by increasing whole-body lipid oxidation 28, 29 while obese and previously obese subjects do not respond in a similar manner. 30, 31 We have recently shown that this metabolic inflexibility occurs at the level of skeletal muscle gene expression following 5 days of a 65% fat diet in a cohort similar to that presented here. 13 To our knowledge, relatively few investigators have examined if this metabolic inflexibility with obesity persists in HSkMC. Myotubes cultured from obese, type 2 diabetics exhibit increased lipid oxidation in response to short-term palmitate incubation (4 h) with evidence of reverse Randle-Cycle activity; 32 although a more prolonged period of lipid incubation (2 days) in a similar diabetic cohort produced a relatively lower increase in total 14 CO 2 production from 14 C-labeled oleate compared with lean, nondiabetic subjects, suggestive of blunted metabolic flexibility. 20 The present findings indicate that this inability to respond appropriately (that is, to the same extent as lean subjects) to lipid presence in HSkMC does not require the overt expression of type 2 diabetes and is present in obese individuals with insulin resistance (Figure 2 ). In addition, previous measurements of lipid metabolism have only been obtained in whole cells as a result of CO 2 production where substrate utilization depends on many factors independent of mitochondrial oxidation. 1,14,17 --20,33,34 For example, cellular uptake, intracellular transport, lipid storage capacity and mitochondrial lipid uptake all have a role in the ability of the mitochondrion to effectively oxidize lipids. Using permeabilized cells and controlled concentrations of PC, we are able to directly measure the capacity of the mitochondrion to oxidize lipids. In addition, ADP-stimulated oxidation rates represent physiological respiration, rather than basal or uncoupled metabolism as reported previously. 1,14,17 --20,33,34 The present findings thus reveal that metabolic inflexibility is evident in mitochondria of skeletal muscle cells derived from insulin resistant, obese, non-diabetic individuals when energy demand is increased to a physiological range (state 3 respiration; Figure 2 ).
Using similar permeabilization techniques in fresh skeletal muscle fibers, others have identified impaired state 3 respiration in tissue from obese, type 2 diabetic patients in the presence of various substrates such as malate þ pyruvate, glutamate and/or succinate. 6, 8, 9, 12 However, no decrement in state 3 respiration with type 2 diabetes was evident with lipid substrate (PC þ malate (PCM)). 8, 12 Recently, we also reported that state 3 respiration in the presence of PCM was similar in permeabilized fibers from lean and obese individuals possessing subject characteristics very similar to those in this study. 6 Although these findings of normal PCM 3 respiration in permeabilized fibers appear to be at odds with the HSkMC data presented here (Figure 2) , it is critical to realize that it is the CONTROL condition in the cell culture experiments that most closely resembles the assessments performed in muscle fibers from diabetic and obese individuals. In light of this comparison, the present HSkMC data corroborate previous reports in permeabilized fibers indicating no difference in PCM 3 and extend those findings to indicate that phenotypic differences in skeletal muscle mitochondrial lipid oxidation with obesity are evident in response to a lipid substrate challenge.
Prolonged lipid exposure can lead to lipid accumulation within the cell 18, 19, 33 as a consequence of nutrient supply outpacing metabolic demand. Excess dietary lipid increases skeletal muscle lipid content in both humans 35 and rodents; 36 and lipid incubation exacerbates phenotypic differences in lipid metabolism where HSkMC from obese individuals express more CD36 and take up more lipid than cells from lean humans. 33 Given the present data, it is plausible that impaired skeletal muscle lipid oxidation may also contribute to the excess intramyocellular lipid content observed in obesity in vivo. In excess, cellular lipids are prone to peroxidation by reactive oxygen species 37 and the ensuing oxidative stress can induce mitochondrial damage, resulting in a cycle of further reductions in substrate oxidation because of reduced mitochondrial numbers and/or altered function.
Mitochondrial biogenesis is a complex process requiring the induction of numerous nuclear and mitochondrial proteins. PGC-1a is a transcriptional coactivator that activates multiple transcription factors, such as nuclear respiratory factor-1, which in turn increase the expression of gene networks involved with and contributing to fatty acid oxidation. 38 In HSkMC, relatively longterm (20 h) lipid incubation (0.5 mM oleate) has been reported to increase PGC-1a mRNA content (B2.5-fold) and mitochondrial activity by B60% (mitochondrial dehydrogenase). 39 We have reported a similar 50% increase in PGC-1a mRNA content in skeletal muscle from lean humans following a 5-day high-fat diet, although obese, insulin-resistant individuals did not respond similarly (B30% decrease). 13 Therefore, it is not surprising that in this study, despite a lower lipid concentration (100 mM), we also observed an increase in mtDNA copy number in cells cultured from lean individuals, while there was a reduction in mtDNA in HSkMC from obese subjects (Figure 3 ). This pattern in mtDNA copy number tended to be similar for COX-IV protein content but was not evident in CS activity measures (Figure 3) . Despite increases in mitochondrial mass there were no concomitant changes in PGC-1a or nuclear respiratory factor-1 protein content in cells from either the lean or obese individuals. Further investigation of lipid-induced mitochondrial biogenesis and/or mitoptosis in skeletal muscle cells cultured from obese individuals is needed in order to discern the potential mechanisms involved.
These conflicting data for mitochondrial content (Figure 3 ) indicate that findings are not consistent among various accepted indices of mitochondrial content and, for this reason, we chose to normalize the respiration data to all three indices to account for the impact of mitochondrial content on the observed increase in state 3 mitochondrial respiration ( Figure 2 ). When respiration data were normalized in this manner it was evident that the LIPID treatment effects observed ( Figure 4 ) were driven by increased mitochondrial respiration in the HSkMC from lean subjects. The severely blunted response observed in HSkMC cultured from the obese subjects is similar to the blunted metabolic flexibility observed by others in HSkMC in response to lipid incubation in whole cells; 19, 20, 34 and indicates that the metabolic perturbation observed with obesity in respect to lipid oxidation may not entirely be explained by potential differences in mitochondrial content.
Previous studies on the role of mitochondrial content and function with respect to lipid oxidation in skeletal muscle of obese or insulin-resistant humans have produced conflicting results. Many investigators have found that lipid oxidation in muscle is depressed in type 2 diabetic patients. 8, 9, 12 This difference, however, was no longer evident when oxidation was normalized to mitochondrial content 9, 11 implying that reduced mitochondrial mass was responsible for any differences in the substrate utilization rate. Others have maintained that there is inherent mitochondrial dysfunction in skeletal muscle of individuals with type 2 diabetes. 8, 12 Clouding this issue is that there is no consensus within the scientific community with regard to a standard index of mitochondrial content. In this context, we utilized several indices of mitochondrial content and consistently observed a contribution from mitochondrial respiration to the metabolic inflexibility induced by lipid incubation in HSkMC with obesity.
In conclusion, the current data utilizing permeabilized HSkMC indicate that the skeletal muscle of obese individuals inherently lacks metabolic flexibility in terms of increasing lipid oxidation in response to lipid exposure (24-h lipid incubation). A novel aspect of our findings is that this inflexibility appears to result from a dampening of the ability to intrinsically enhance the capacity for lipid oxidation relative to mitochondrial content and, perhaps, in the ability to increase mitochondrial mass in response to increased lipid availability.
